Atlas of Apoptosis
Atlas of Apoptosis
Atlas of Apoptosis
term programmed cell necrosis, but in the article, the process of natural cell death was called apoptosis. Kerr, Wyllie and Currie credited James Cormack, a professor of
Greek language at University of Aberdeen, with suggesting the term apoptosis. Kerr received the Paul Ehrlich and
Ludwig Darmstaedter Prize on March 14, 2000, for his
description of apoptosis. He shared the prize with Boston
biologist H. Robert Horvitz.[10] The 2002 Nobel Prize in
Medicine was awarded to Sydney Brenner, Horvitz and
John E. Sulston for their work identifying genes that control apoptosis. The genes were identied by studies in
the nematode C. elegans and these same genes function
in humans for apoptosis.
John E. Sulston won the Nobel Prize in Medicine in 2002, for his
pioneering research on apoptosis.
Main article: History and highlights in apoptosis research In Greek, apoptosis translates to the dropping o of
petals or leaves from plants or trees. Cormack, profesGerman scientist Karl Vogt was rst to describe the prin- sor of Greek language, reintroduced the term for mediciple of apoptosis in 1842. In 1885, anatomist Walther cal use as it had a medical meaning for the Greeks over
Flemming delivered a more precise description of the two thousand years before. Hippocrates used the term
process of programmed cell death. However, it was not to mean the falling o of the bones. Galen extended
until 1965 that the topic was resurrected. While studying its meaning to the dropping of the scabs. Cormack
tissues using electron microscopy, John Foxton Ross Kerr was no doubt aware of this usage when he suggested the
at University of Queensland was able to distinguish apop- name. Debate continues over the correct pronunciation,
tosis from traumatic cell death.[7] Following the publica- with opinion divided between a pronunciation with the
tion of a paper describing the phenomenon, Kerr was in- second p silent (/ptoss/ ap--TOH-sis[2][11] ) and the
vited to join Alastair R Currie, as well as Andrew Wyllie, second p pronounced (/pptoss/),[2][12] as in the origwho was Curries graduate student,[8] at University of Ab- inal Greek. In English, the p of the Greek -pt- consonant
erdeen. In 1972, the trio published a seminal article in the cluster is typically silent at the beginning of a word (e.g.
British Journal of Cancer.[9] Kerr had initially used the pterodactyl, Ptolemy), but articulated when used in com1
2 PROCESS
Process
A cell initiates intracellular apoptotic signaling in response to a stress, which may bring about cell suicide.
The binding of nuclear receptors by glucocorticoids,[13]
heat,[13] radiation,[13] nutrient deprivation,[13] viral
infection,[13] hypoxia[13] and increased intracellular
calcium concentration,[14] for example, by damage to
the membrane, can all trigger the release of intracellular
apoptotic signals by a damaged cell. A number of cellular
components, such as poly ADP ribose polymerase, may
also help regulate apoptosis.[15]
Before the actual process of cell death is precipitated by
enzymes, apoptotic signals must cause regulatory proteins to initiate the apoptosis pathway. This step allows
apoptotic signals to cause cell death, or the process to be
stopped, should the cell no longer need to die. Several
proteins are involved, but two main methods of regulation
have been identied: targeting mitochondria functionality, or directly transducing the signal via adaptor proteins
to the apoptotic mechanisms. Another extrinsic pathway
for initiation identied in several toxin studies is an increase in calcium concentration within a cell caused by
drug activity, which also can cause apoptosis via a calcium binding protease calpain.
2.1
Mitochondrial regulation
2.2
TRAIL R2
Fasl / Fas
Cadherine E - Cathenine
Extrinsic Pathway
Intrinsic Pathway
p53
Stress
PUMA
p73/p63
Dvp
Perforine
anti-apoptotic protein
Noxa
bax/bax
binding
Bcl-xl
Bcl-2
Cytochrome C in the
intermembrane space
bak/bak
COOH
Fas Associated
Death Domain
(FADD)
Apaf-1
Release of cytochrome C
and binding on Apaf-1
Injured Mitochondrion
Nucleus
damaged
DNA
TGF, TGF
Grandzyme
CAspase Recruitment
Domain (CARD)
dATP
Apoptosome
Pro-caspase 9 Activation
big subunit
small
subunit
tBid
Caspase 9 inactivated initiator
Bid
(BH3)
T Lympocyte
Caspase 1
activated
effector
Phagocyte
Short Pro-Domain
Caspases Cascade
phosphatidylserine
outsourcing
Inactivated
TFN-R1
TFN
APOPTOSIS
intranuclosomal degradation of
DNA
Intracellular
death domain
Transcription
factors
activated
Apoptosis
Indirect
ion
activat
TRADD
FADD
Caspase
activation
Pro-caspase 8
Inactivated
Fas receptor
FasL
Intracellular
death domain
FADD
Apoptosis
Caspase
activation
Pro-caspase 8
Two theories of the direct initiation of apoptotic mechanisms in mammals have been suggested: the TNF-induced
(tumour necrosis factor) model and the Fas-Fas ligandMAC (not to be confused with the Membrane Attack mediated model, both involving receptors of the TNF reComplex formed by complement activation, also com- ceptor (TNFR) family[23] coupled to extrinsic signals.
monly denoted as MAC), also called Mitochondrial
Outer Membrane Permeabilization Pore is regulated by
various proteins, such as those encoded by the mam- 2.2.1 TNF Path
malian Bcl-2 family of anti-apoptopic genes, the homologs of the ced-9 gene found in C. elegans.[21][22] Bcl-2 TNF is a cytokine produced mainly by activated
proteins are able to promote or inhibit apoptosis by direct macrophages, and is the major extrinsic mediator of
action on MAC/MOMPP. Bax and/or Bak form the pore, apoptosis. Most cells in the human body have two rewhile Bcl-2, Bcl-xL or Mcl-1 inhibit its formation.
ceptors for TNF: TNF-R1 and TNF-R2. The binding of
4
TNF to TNF-R1 has been shown to initiate the pathway that leads to caspase activation via the intermediate membrane proteins TNF receptor-associated death domain (TRADD) and Fas-associated death domain protein
(FADD). cIAP1/2 can inhibit TNF- signaling by binding to TRAF2. FLIP inhibits the activation of caspase8.[24] Binding of this receptor can also indirectly lead
to the activation of transcription factors involved in cell
survival and inammatory responses.[25] However, signalling through TNF-R1 might also induce apoptosis in a
Caspase-independent manner.[26] The link between TNF
and apoptosis shows why an abnormal production of TNF
plays a fundamental role in several human diseases, especially in autoimmune diseases.
2 PROCESS
eector caspases then proteolytically degrade a host of
intracellular proteins to carry out the cell death program.
2.2.4 Caspase-independent apoptotic pathway
There also exists a caspase-independent apoptotic pathway that is mediated by AIF (apoptosis-inducing factor).[29]
2.3 Execution
5
cytosolic surface of the plasma membrane, but is redistributed during apoptosis to the extracellular surface by a
protein known as scramblase.[37] These molecules mark
the cell for phagocytosis by cells possessing the appropriate receptors, such as macrophages.[38] Upon recognition, the phagocyte reorganizes its cytoskeleton for engulfment of the cell. The removal of dying cells by phagocytes occurs in an orderly manner without eliciting an
inammatory response.[38]
the brain and abnormal apoptotic features such as membrane blebbing or nuclear fragmentation. A remarkable
feature of these KO mice is that they have a very restricted
phenotype: Casp3, 9, APAF-1 KO mice have deformations of neural tissue and FADD and Casp 8 KO showed
defective heart development, however in both types of
KO other organs developed normally and some cell types
were still sensitive to apoptotic stimuli suggesting that unknown proapoptotic pathways exist.
Pathway knock-outs
Many knock-outs have been made in the apoptosis pathways to test the function of each of the proteins. Several caspases, in addition to APAF-1 and FADD, have
been mutated to determine the new phenotype. In order to create a tumor necrosis factor (TNF) knockout,
an exon containing the nucleotides 3704-5364 was removed from the gene. This exon encodes a portion of
the mature TNF domain, as well as the leader sequence,
which is a highly conserved region necessary for proper
intracellular processing. TNF-/- mice develop normally
and have no gross structural or morphological abnormalities. However, upon immunization with SRBC (sheep
red blood cells), these mice demonstrated a deciency in
the maturation of an antibody response; they were able
to generate normal levels of IgM, but could not develop
specic IgG levels. Apaf-1 is the protein that turns on
caspase 9 by cleavage to begin the caspase cascade that
leads to apoptosis. Since a -/- mutation in the APAF-1
gene is embryonic lethal, a gene trap strategy was used
in order to generate an APAF-1 -/- mouse. This assay
is used to disrupt gene function by creating an intragenic
gene fusion. When an APAF-1 gene trap is introduced
into cells, many morphological changes occur, such as
spina bida, the persistence of interdigital webs, and open
brain. In addition, after embryonic day 12.5, the brain of
the embryos showed several structural changes. APAF-1
cells are protected from apoptosis stimuli such as irradiation. A BAX-1 knock-out mouse exhibits normal forebrain formation and a decreased programmed cell death
in some neuronal populations and in the spinal cord, leading to an increase in motor neurons.
The caspase proteins are integral parts of the apoptosis
pathway, so it follows that knock-outs made have varying damaging results. A caspase 9 knock-out leads to a
severe brain malformation. A caspase 8 knock-out leads
to cardiac failure and thus embryonic lethality. However,
with the use of cre-lox technology, a caspase 8 knock-out
has been created that exhibits an increase in peripheral T
cells, an impaired T cell response, and a defect in neural
tube closure. These mice were found to be resistant to
apoptosis mediated by CD95, TNFR, etc. but not resistant to apoptosis caused by UV irradiation, chemotherapeutic drugs, and other stimuli. Finally, a caspase 3
knock-out was characterized by ectopic cell masses in
5 Implication in disease
5.1 Defective pathways
The many dierent types of apoptotic pathways contain
a multitude of dierent biochemical components, many
of them not yet understood.[40] As a pathway is more or
less sequential in nature, it is a victim of causality; removing or modifying one component leads to an eect
in another. In a living organism, this can have disastrous
eects, often in the form of disease or disorder. A discussion of every disease caused by modication of the
various apoptotic pathways would be impractical, but the
concept overlying each one is the same: The normal functioning of the pathway has been disrupted in such a way as
to impair the ability of the cell to undergo normal apoptosis. This results in a cell that lives past its use-by-date
IMPLICATION IN DISEASE
5.2 Inhibition
A section of mouse liver showing several apoptotic cells, indicated
by arrows
and is able to replicate and pass on any faulty machinery to its progeny, increasing the likelihood of the cells
becoming cancerous or diseased.
A recently described example of this concept in action
can be seen in the development of a lung cancer called
NCI-H460.[41] The X-linked inhibitor of apoptosis protein (XIAP) is overexpressed in cells of the H460 cell
line. XIAPs bind to the processed form of caspase-9, and
suppress the activity of apoptotic activator cytochrome
c, therefore overexpression leads to a decrease in the
amount of proapoptotic agonists. As a consequence, the
balance of anti-apoptotic and proapoptotic eectors is
upset in favour of the former, and the damaged cells continue to replicate despite being directed to die.
5.4
HIV progression
5.2.2
Apoptosis is a multi-step, multi-pathway cell-death programme that is inherent in every cell of the body. In
cancer, the apoptosis cell-division ratio is altered. Cancer treatment by chemotherapy and irradiation kills target
cells primarily by inducing apoptosis.
Hyperactive apoptosis
On the other hand, loss of control of cell death (resulting in excess apoptosis) can lead to neurodegenerative
diseases, hematologic diseases, and tissue damage. The
progression of HIV is directly linked to excess, unregulated apoptosis. In a healthy individual, the number of
CD4+ lymphocytes is in balance with the cells generated
by the bone marrow; however, in HIV-positive patients,
this balance is lost due to an inability of the bone marrow
to regenerate CD4+ cells. In the case of HIV, CD4+ lymphocytes die at an accelerated rate through uncontrolled
apoptosis, when stimulated.
5.3.1
leads to NF-B activation and cell survival. Active NFB induces the expression of anti-apoptotic genes such
as Bcl-2, resulting in inhibition of apoptosis. NF-B
has been found to play both an antiapoptotic role and a
proapoptotic role depending on the stimuli utilized and
the cell type.[48]
Treatments
5.3
Treatments
Treatments aiming to inhibit works to block specic caspases. Finally, the Akt protein kinase promotes cell survival through two pathways. Akt phosphorylates and inhibits Bas (a Bcl-2 family member), causing Bas to interact with the 14-3-3 scaold, resulting in Bcl dissociation Viruses can trigger apoptosis of infected cells via a range
and thus cell survival. Akt also activates IKK, which of mechanisms including:
7 CASPASE-INDEPENDENT APOPTOSIS
Receptor binding
Activation of protein kinase R (PKR)
Interaction with p53
Expression of viral proteins coupled to MHC proteins on the surface of the infected cell, allowing
recognition by cells of the immune system (such as
Natural Killer and cytotoxic T cells) that then induce
the infected cell to undergo apoptosis.[53]
Canine distemper virus (CDV) is known to cause apoptosis in central nervous system and lymphoid tissue of infected dogs in vivo and in vitro.[54] Apoptosis caused by
CDV is typically induced via the extrinsic pathway, which
activates caspases that disrupt cellular function and eventually leads to the cells death.[43] In normal cells, CDV activates caspase-8 rst, which works as the initiator protein
followed by the executioner protein caspase-3.[43] However, apoptosis induced by CDV in HeLa cells does not
involve the initiator protein caspase-8. HeLa cell apoptosis caused by CDV follows a dierent mechanism than
that in vero cell lines.[43] This change in the caspase cascade suggests CDV induces apoptosis via the intrinsic
pathway, excluding the need for the initiator caspase8. The executioner protein is instead activated by the
internal stimuli caused by viral infection not a caspase
cascade.[43]
7 Caspase-independent apoptosis
The characterization of the caspases allowed the development of caspase inhibitors, which can be used to determine whether a cellular process involves active caspases.
Using these inhibitors it was discovered that cells can die
while displaying a morphology similar to apoptosis without caspase activation.[63] Later studies linked this phenomenon to the release of AIF (apoptosis-inducing factor) from the mitochondria and its translocation into the
9
nucleus mediated by its NLS (nuclear localization signal).
Inside the mitochondria, AIF is anchored to the inner
membrane. In order to be released, the protein is cleaved
by a calcium-dependent calpain protease.
In 2003, a method was developed for predicting subcellular location of apoptosis proteins.[64] Subsequent to this,
various modes of Chous pseudo amino acid composition were developed for improving the quality of predicting subcellular localization of apoptosis proteins based on
their sequence information alone. [65] [66] [67] [68]
See also
Anoikis
Apaf-1
Apo2.7
Apoptotic DNA fragmentation
Atromentin induces apoptosis in human leukemia
U937 cells.[69]
Autolysis
Autophagy
Cisplatin
Entosis
Immunology
Paraptosis
Necrobiosis
Necrosis
Necrotaxis
p53
cytotoxicity
Pseudoapoptosis
10
References
10
10
Map for
Science
Tumor
STKE.
REFERENCES
[31] Susin, S; Daugas, E; Ravagnan, L; Samejima, K; Zamzami, N; Loeer, M; Costantini, P; Ferri, KF et al.
(2000). Two Distinct Pathways Leading to Nuclear
Apoptosis. Journal of Experimental Medicine 192 (4):
57180. doi:10.1084/jem.192.4.571. PMC 2193229.
PMID 10952727.
[32] Madeleine Kihlmark; Imreh, G; Hallberg, E (15 October
2001). Sequential degradation of proteins from the nuclear envelope during apoptosis. Journal of Cell Science
114 (20): 364353. PMID 11707516.
[33] Nagata S (April 2000).
Apoptotic DNA fragmentation.
Exp.
Cell Res.
256 (1): 128.
doi:10.1006/excr.2000.4834. PMID 10739646.
[34] M Iwata, D Myerson, B Torok-Storb and RA Zager
(1996). An evaluation of renal tubular DNA laddering in
response to oxygen deprivation and oxidant injury. Retrieved 2006-04-17.
[35] Vandivier RW, Henson PM, Douglas IS (June 2006).
Burying the dead: the impact of failed apoptotic
cell removal (eerocytosis) on chronic inammatory lung disease.
Chest 129 (6): 167382.
doi:10.1378/chest.129.6.1673. PMID 16778289.
[36] Li MO; Sarkisian, MR; Mehal, WZ; Rakic, P; Flavell,
RA (2003). Phosphatidylserine receptor is required for
clearance of apoptotic cells. Science 302 (5650): 1560
3. doi:10.1126/science.1087621. PMID 14645847.
[37] Wang X; Wu, YC; Fadok, VA; Lee, MC; GengyoAndo, K; Cheng, LC; Ledwich, D; Hsu, PK et
al. (2003). Cell corpse engulfment mediated by
C. elegans phosphatidylserine receptor through CED5 and CED-12. Science 302 (5650): 15631566.
doi:10.1126/science.1087641. PMID 14645848.
[38] Savill J, Gregory C, Haslett C. (2003).
Eat
me or die.
Science 302 (5650):
15167.
doi:10.1126/science.1092533. PMID 14645835.
[39] Krysko DV, Vanden Berghe T, Parthoens E, D'Herde
K, Vandenabeele P. (2008).
Methods for distinguishing apoptotic from necrotic cells and measuring their clearance..
Methods Enzymol.
442:
30741. doi:10.1016/S0076-6879(08)01416-X. PMID
18662577.
[40] Thompson, CB (1995). Apoptosis in the pathogenesis
and treatment of disease. Science 267 (5203): 145662.
doi:10.1126/science.7878464. PMID 7878464.
[41] Yang L, Mashima T, Sato S (February 2003).
Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer
H460 cells: therapeutic eect of a novel polyarginineconjugated Smac peptide. Cancer Res. 63 (4): 8317.
PMID 12591734.
[42] Takaoka A; Hayakawa, S; Yanai, H; Stoiber, D; Negishi,
H; Kikuchi, H; Sasaki, S; Imai, K et al. (2003). Integration of interferon-alpha/beta signalling to p53 responses
in tumour suppression and antiviral defence. Nature
424 (6948): 51623. doi:10.1038/nature01850. PMID
12872134.
11
[44] Liu HC, Chen GG, Vlantis AC, Tse GM, Chan AT, van
Hasselt CA (March 2008). Inhibition of apoptosis in human laryngeal cancer cells by E6 and E7 oncoproteins of
human papillomavirus 16. J. Cell. Biochem. 103 (4):
112543. doi:10.1002/jcb.21490. PMID 17668439.
[45] Niu XY, Peng ZL, Duan WQ, Wang H, Wang P (2006).
Inhibition of HPV 16 E6 oncogene expression by RNA
interference in vitro and in vivo. Int. J. Gynecol. Cancer
16 (2): 74351. doi:10.1111/j.1525-1438.2006.00384.x.
PMID 16681755.
[58] Teodoro, J.G. Branton, P.E. (1997). Regulation of apoptosis by viral gene products. J Virol 71 (3): 173946.
PMC 191242. PMID 9032302.
[46] Liu Y, McKalip A, Herman B. (2000) Human Papillomavirus Type 16 E6 and HPV-16 E6/E7 Sensitize Human
Keratinocytes to Apoptosis Induced by Chemotherapeutic
Agents: Roles of p53 and Caspase Activation. Journal of
Cellular Biochemistry 78:334349
[47] Boehm, I. (2006).
Apoptosis in physiological
and pathological skin:
Implications for therapy. Current molecular medicine 6 (4): 375394.
doi:10.2174/156652406777435390. PMID 16900661.
[48] Farhana, Lulu. Apoptosis Induction by a Novel RetinoidRelated Molecule Requires Nuclear Factor- B Activation. American Association of Cancer Research
(AACR). Retrieved 2012-01-24.
[49] Judie B. Alimonti, T. Blake Ball, Keith R. Fowke (2003).
Mechanisms of CD4+ T lymphocyte cell death in human immunodeciency virus infection and AIDS. J Gen
Virology 84 (7): 164961. doi:10.1099/vir.0.19110-0.
PMID 12810858.
[50] Vashistha H, Husain M, Kumar D, Yadav A, Arora S,
Singhal PC. (2008)Ren Fail. 2008;30(6):655-64.
[51] 2013 Indiana University Health. AIDS Dening Criteria | Riley. IU Health. Retrieved 2013-01-20.
[52] Indran IR, Tufo G, Pervaiz S, Brenner C (June 2011).
Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim. Biophys. Acta 1807
(6): 73545. doi:10.1016/j.bbabio.2011.03.010. PMID
21453675.
[53] Everett, H. and McFadden, G. (1999). Apoptosis: an innate immune response to virus infection. Trends Microbiol 7 (4): 1605. doi:10.1016/S0966-842X(99)014870. PMID 10217831.
[54] Nishi T, Tsukiyama-Kohara K, Togashi K, Kohriyama N,
Kai C (November 2004). Involvement of apoptosis in
syncytial cell death induced by canine distemper virus.
Comp. Immunol. Microbiol. Infect. Dis. 27 (6): 44555.
doi:10.1016/j.cimid.2004.01.007. PMID 15325517.
[55] Acrani GO, Gomes R, Proena-Mdena JL, et al.
(April 2010). Apoptosis induced by Oropouche virus
infection in HeLa cells is dependent on virus protein expression.
Virus Res.
149 (1): 5663.
doi:10.1016/j.virusres.2009.12.013. PMID 20080135.
12
11
11
External links
Discovering Pro-
EXTERNAL LINKS
13
12
12.1
12.2
Images
14
12
12.3
Content license